ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,995
0,54%
Bitcoin
57 478,03
-1,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gossamer Bio Inc (GOSS)

  7. Gossamer Bio Inc (GOSS) Actualités

GOSS Gossamer Bio Inc

0,70
-0,01 (-1,41%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gossamer Bio Inc GOSS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,01 -1,41% 0,70 01:59:59
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,71 0,69 0,75 0,7075 0,71
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
12/3/202412:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
05/3/202413:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:31EDGAR2Form 8-K - Current report
05/3/202413:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
04/3/202422:02EDGAR2Form 8-K - Current report
08/1/202422:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
04/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:01BWGossamer Bio to Host Webcast to Discuss Latest Seralutinib..
05/12/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202322:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
05/12/202313:01BWGossamer Bio Appoints Bob Smith as Chief Commercial Officer
29/11/202322:01EDGAR2Form 8-K - Current report
29/11/202313:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
27/11/202322:01EDGAR2Form 8-K - Current report
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:31EDGAR2Form 8-K - Current report
09/11/202313:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
20/10/202322:01EDGAR2Form 8-K - Current report
03/10/202322:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
07/9/202323:00EDGAR2Form 8-K - Current report
07/9/202313:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
29/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
28/8/202322:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/202322:01EDGAR2Form DEL AM - Delaying amendment
18/8/202314:41EDGAR2Form S-3 - Registration statement under Securities Act of..
18/8/202314:38EDGAR2Form RW - Registration Withdrawal Request
17/8/202322:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:01EDGAR2Form 8-K - Current report
08/8/202322:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
28/7/202321:46EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/7/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:16BWGossamer Bio to Hold Conference Call with PAH Experts to..
20/7/202322:01EDGAR2Form 8-K - Current report
20/7/202313:56BWGossamer Bio Announces $212 Million Private Placement..
20/7/202313:50EDGAR2Form 8-K - Current report
18/5/202313:05BWGossamer Bio Announces TORREY Data to be Featured at..
09/5/202322:01BWGossamer Bio Announces First Quarter 2023 Financial Results..

Dernières Valeurs Consultées

NASDAQ
GOSS
Gossamer Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés